Cargando…

Single-Domain Antibodies As Therapeutics against Human Viral Diseases

In full-size formats, monoclonal antibodies have been highly successful as therapeutics against cancer and immune diseases. However, their large size leads to inaccessibility of some epitopes and relatively high production costs. As an alternative, single-domain antibodies (sdAbs) offer special adva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yanling, Jiang, Shibo, Ying, Tianlei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733491/ https://www.ncbi.nlm.nih.gov/pubmed/29326699 http://dx.doi.org/10.3389/fimmu.2017.01802

Ejemplares similares

Single-Domain Antibodies as Therapeutics for Respiratory RNA Virus Infections
por: Huang, Keke, et al.
Publicado: (2022)

In-Depth Analysis of Human Neonatal and Adult IgM Antibody Repertoires
por: Hong, Binbin, et al.
Publicado: (2018)

Identification of Human Single-Domain Antibodies against SARS-CoV-2
por: Wu, Yanling, et al.
Publicado: (2020)

Editorial: Antibody Fc Engineering: Towards Better Therapeutics
por: Lei, Cheng, et al.
Publicado: (2018)

The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2
por: Li, Cheng, et al.
Publicado: (2021)

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020)

Human monoclonal antibodies as candidate therapeutics against emerging viruses
por: Jin, Yujia, et al.
Publicado: (2017)

Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
por: Wu, Yanling, et al.
Publicado: (2017)

A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
por: Yang, Zhenlin, et al.
Publicado: (2021)

A comparison of the binding sites of antibodies and single-domain antibodies
por: Gordon, Gemma L., et al.
Publicado: (2023)

Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer
por: Huang, Bilian, et al.
Publicado: (2021)

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
por: Ying, Tianlei, et al.
Publicado: (2015)

Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4(+) Cells
por: Traenkle, Bjoern, et al.
Publicado: (2021)

Interactions of IgG1 CH2 and CH3 Domains with FcRn
por: Ying, Tianlei, et al.
Publicado: (2014)

Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
por: Li, Cheng, et al.
Publicado: (2022)

Complexity of Viral Epitope Surfaces as Evasive Targets for Vaccines and Therapeutic Antibodies
por: Miller, Nathaniel L., et al.
Publicado: (2022)

Therapeutic Antibodies against Intracellular Tumor Antigens
por: Trenevska, Iva, et al.
Publicado: (2017)

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
por: Tian, Xiaolong, et al.
Publicado: (2020)

Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
por: Arbabi-Ghahroudi, Mehdi
Publicado: (2017)

Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview
por: Goldman, Ellen R., et al.
Publicado: (2017)

Editorial: Single-Domain Antibodies—Biology, Engineering and Emerging Applications
por: Henry, Kevin A., et al.
Publicado: (2018)

Single Domain Antibody application in bacterial infection diagnosis and neutralization
por: Qin, Qian, et al.
Publicado: (2022)

Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
por: Panova, Eugenia A., et al.
Publicado: (2023)

A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors
por: Wu, Yanling, et al.
Publicado: (2022)

Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 Infection
por: Wang, Xinling, et al.
Publicado: (2021)

Humanized single-domain antibody targeting HER2 enhances function of chimeric antigen receptor T cells
por: Zheng, Rui, et al.
Publicado: (2023)

One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells
por: Li, Wei, et al.
Publicado: (2017)

Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions
por: Beirnaert, Els, et al.
Publicado: (2017)

Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications
por: Gonzalez-Sapienza, Gualberto, et al.
Publicado: (2017)

Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment
por: Iezzi, María Elena, et al.
Publicado: (2018)

Potential Therapeutic Applications of Pulmonary Surfactant Lipids in the Host Defence Against Respiratory Viral Infections
por: Ji, Jianjian, et al.
Publicado: (2021)

Potent Therapeutic Strategies for COVID-19 with Single-Domain Antibody Immunoliposomes Neutralizing SARS-CoV-2 and Lip/cGAMP Enhancing Protective Immunity
por: Zhou, Yajun, et al.
Publicado: (2023)

Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy
por: Zhu, Xiaoyi, et al.
Publicado: (2021)

Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS)
por: Lu, Lu, et al.
Publicado: (2015)

Camelid Single-Domain Antibodies As an Alternative to Overcome Challenges Related to the Prevention, Detection, and Control of Neglected Tropical Diseases
por: Fernandes, Carla F. C., et al.
Publicado: (2017)

Double lock of a potent human therapeutic monoclonal antibody against SARS-CoV-2
por: Zhu, Ling, et al.
Publicado: (2020)

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III
por: Hu, Dan, et al.
Publicado: (2019)

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
por: Xia, Shuai, et al.
Publicado: (2020)

Under the Microscope: Single-Domain Antibodies for Live-Cell Imaging and Super-Resolution Microscopy
por: Traenkle, Bjoern, et al.
Publicado: (2017)

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
por: Favorskaya, Irina A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hgqhk5e6pnjujnea3t8omigi1o